Rosiglitazone for HIV-1 lipoatrophy

Lancet. 2004 May 29;363(9423):1828-9; author reply 1829. doi: 10.1016/S0140-6736(04)16318-6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • HIV-Associated Lipodystrophy Syndrome / drug therapy*
  • Humans
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use*

Substances

  • Thiazolidinediones
  • Rosiglitazone